Special Issue "New Frontiers in Head and Neck Oncology"
Deadline for manuscript submissions: closed (30 November 2022) | Viewed by 25250
Interests: head and neck oncology; brain tumors
Interests: HNSCC; immunotherapy; biomarkers; mRCC; targeted therapy; DPYD
Special Issues, Collections and Topics in MDPI journals
Interests: HNSCC; translational research; pharmacogenomics
The field of head and neck oncology is evolving very rapidly. The importance of achieving an uncomplicated cure has become very clear to all healthcare professionals in this area. Moreover, the continuously increasing incidence of HPV-related oropharyngeal cancer in young and usually healthy patients has stimulated significant clinical research to de-intensify treatment in current clinical trials around the world. At the same time, there is an increase in life expectancy and patients presenting with curable disease in their seventies and eighties. New therapeutic approaches are needed to provide adequate therapy in the context of treatment-related side effects. This is another area of urgent research to achieve a better therapeutic ratio without increasing patients’ symptoms burden. In addition, the importance of patient-reported outcomes (PRO) and QOL are essential components of all attempts to better understand the impact of treatment on patients and how we can improve their experience.
Dr. George Shenouda
Prof. Dr. Denis Soulieres
Dr. Houda Bahig
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Head and neck cancer
- Oropharyngeal HPV-related cancer
- Treatment de-intensification
- Patient-reported outcomes
- Quality of Life